Charles Schwab’s Nomura Holdings NMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.3M Buy
945,860
+102,134
+12% +$850K ﹤0.01% 2247
2026
Q1
$6.66M Buy
843,726
+105,077
+14% +$905K ﹤0.01% 2281
2025
Q4
$6.2M Buy
738,649
+100,133
+16% +$748K ﹤0.01% 2351
2025
Q3
$4.64M Buy
638,516
+111,663
+21% +$784K ﹤0.01% 2473
2025
Q2
$3.47M Buy
526,853
+64,206
+14% +$376K ﹤0.01% 2487
2025
Q1
$2.85M Buy
462,647
+80,540
+21% +$513K ﹤0.01% 2505
2024
Q4
$2.21M Buy
382,107
+70,216
+23% +$399K ﹤0.01% 2645
2024
Q3
$1.63M Sell
311,891
-15,282
-5% -$86.8K ﹤0.01% 2766
2024
Q2
$1.89M Buy
327,173
+37,093
+13% +$220K ﹤0.01% 2723
2024
Q1
$1.86M Buy
290,080
+68,774
+31% +$382K ﹤0.01% 2612
2023
Q4
$998K Buy
221,306
+93,200
+73% +$383K ﹤0.01% 2834
2023
Q3
$515K Buy
128,106
+49,998
+64% +$199K ﹤0.01% 3028
2023
Q2
$299K Buy
78,108
+27,145
+53% +$100K ﹤0.01% 3230
2023
Q1
$194K Buy
50,963
+18,682
+58% +$73.7K ﹤0.01% 3161
2022
Q4
$121K Buy
+32,281
New +$112K ﹤0.01% 3240

Other funds holding NMR

Charles Schwab's NMR Position: Q2 2026 in Review

Charles Schwab increased its Nomura Holdings (NMR) stake by 12% in Q2 2026, buying an estimated $850K and bringing the position to 945,860 shares worth $8.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2247.

Charles Schwab first reported a position in NMR in Q4 2022 and has held it in 15 quarters since. 300 funds tracked by Wall St. Rank hold NMR as of Q2 2026.

  • Charles Schwab held 945,860 shares of Nomura Holdings worth $8.3M as of Q2 2026.
  • Charles Schwab bought 102,134 Nomura Holdings shares in Q2 2026, an estimated $850K.
  • Nomura Holdings made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #2247 holding.
  • Charles Schwab first reported a position in Nomura Holdings in Q4 2022 and has held it in 15 quarters since.
  • 300 funds tracked by Wall St. Rank held Nomura Holdings as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.